comparemela.com

Latest Breaking News On - Company media enquiries - Page 2 : comparemela.com

Opthea Receives A$8.8 million R&D Tax Incentive

MELBOURNE, Australia, Dec. 19, 2023 Opthea Limited , a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced.

Australia
Melbourne
Victoria
Australian
Fred-guerard
Rudi-michelson
Hershel-berry
Company-media-enquiries
Nasdaq
Opthea-limited
Australian-taxation-office
Investment-in-biotechnology-companies

Opthea to Present at the FLORetina 2023 Congress

Opthea to Present at the FLORetina 2023 Congress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Italy
Rome
Lazio
Australia
Melbourne
Victoria
Rudi-michelson
Peter-lang
Hershel-berry
Frederic-guerard
Angelo-maria-minnella
Policlinicoa-gemelli

Opthea : to Present at the FLORetina 2023 Congress - Form 6-K -November 30, 2023 at 06:09 am EST

Opthea to Present at the FLORetina 2023 Congress Melbourne, Australia; 30 November 2023 - Opthea Limited , a clinical stage biopharmaceutical company developing novel therapies.

Melbourne
Victoria
Australia
Italy
Rome
Lazio
Rudi-michelson
Hershel-berry
Policlinicoa-gemelli
Jeremy-levin
Peter-lang
Angelo-maria-minnella

Opthea to Present at the Jefferies 2023 London Healthcare Conference

Opthea to Present at the Jefferies 2023 London Healthcare Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Australia
Melbourne
Victoria
Rudi-michelson
Peter-lang
Frederic-guerard
Megan-baldwin
Kelly-shi
Hershel-berry
Company-founder
Nasdaq
Investment-in-biotechnology-companies

Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conference

MELBOURNE, Australia, Oct. 30, 2023 Opthea Limited , a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced.

San-francisco
California
United-states
Melbourne
Victoria
Australia
American
Rudi-michelson
Hershel-berry
Peter-lang
Frederic-guerard
Megan-baldwin

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.